Cleared Traditional

K791642 - A-GENT GLYCOSPEC

K791642 is an FDA 510(k) clearance for A-GENT GLYCOSPEC, manufactured by Abbott Laboratories. The device is a Class 2 Hematology device with product code LCP cleared through the Traditional 510(k) pathway after a 55-day FDA review.

K791642 · Abbott Laboratories · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1979
Decision
55d
Days
Class 2
Risk

K791642 is an FDA 510(k) clearance for the A-GENT GLYCOSPEC. Classified as Assay, Glycosylated Hemoglobin (product code LCP), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on October 17, 1979 after a review of 55 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7470 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K791642

510(k) Number K791642 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 23, 1979
Decision Date October 17, 1979
Days to Decision 55 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 113d · This submission: 55d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LCP Device Classification - Class 2, Special Controls

Product Code LCP Assay, Glycosylated Hemoglobin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7470
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - LCP Assay, Glycosylated Hemoglobin

All 149
Devices cleared under the same product code (LCP) and FDA review panel - the closest regulatory comparables to K791642.
LEECO GLYCO-HEMOGLOBIN DIAG. TEST KIT
K801289 · Leeco Diagnostics, Inc. · Jun 1980
FAST HEMOGLOBIN CONTROL-LYOPHILIZED
K800794 · Isolab, Inc. · Apr 1980
CORNING GLYCOSYLATED HEMOGLOBIN SET
K791777 · Corning Medical & Scientific · Nov 1979
FAST FLOW #60310
K791365 · Hi Chem, Inc. · Sep 1979
GLUCOHEMOGLOBIN CONTROL
K791428 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Aug 1979
LEECO GLYCO-HEMOGLOBIN DIAGNOSTIC KIT
K791103 · Leeco Diagnostics, Inc. · Jun 1979